Sequential anti-inflammatory and osteogenic effects of a dual drug delivery scaffold loaded with parthenolide and naringin in periodontitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Our pilot study showed that a 3-dimensional dual drug delivery scaffold (DDDS) loaded with Chinese herbs significantly increased the regenerated bone volume fraction. This study aimed to confirm the synergistic anti-inflammatory and osteogenic preclinical effects of this system. Methods: The targets and pathways of parthenolide and naringin were predicted. Three cell models were used to assess the anti-inflammatory effects of parthenolide and the osteogenic effects of naringin. First, the distance between the cementoenamel junction and alveolar bone crest (CEJ-ABC) and the bone mineral density (BMD) of surgical defects were measured in a rat model of periodontitis with periodontal fenestration defects. Additionally, the mRNA expression levels of matrix metallopeptidase 9 (MMP9) and alkaline phosphatase (ALP) were measured. Furthermore, the number of inflammatory cells and osteoclasts, as well as the protein expression levels of tumor necrosis factor-alpha (TNF-α) and levels of ALP were determined. Results: Target prediction suggested prostaglandin peroxidase synthase (PTGS2) as a potential target of parthenolide, while cytochrome P450 family 19 subfamily A1 (CYP19A1) and taste 2 receptor member 31 (TAS2R31) were potential targets of naringin. Parthenolide mainly targeted inflammation-related pathways, while naringin participated in steroid hormone synthesis and taste transduction. In vitro experiments revealed significant antiinflammatory effects of parthenolide on RAW264.7 cells, and significant osteogenic effects of naringin on bone marrow mesenchymal stem cells and MC3T3-E1 cells. DDDS loaded with parthenolide and naringin decreased the CEJ-ABC distance and increased BMD and ALP levels in a time-dependent manner. Inflammation was significantly alleviated after 14 days of DDDS treatment. Additionally, after 56 days, the DDDS group exhibited the highest BMD and ALP levels. Conclusions: DDDS loaded with parthenolide and naringin in a rat model achieved significant synergistic anti-inflammatory and osteogenic effects, providing powerful preclinical evidence.
Abstract
Purpose: Our pilot study showed that a 3-dimensional dual drug delivery scaffold (DDDS) loaded with Chinese herbs significantly increased the regenerated bone volume fraction. This study aimed to confirm the synergistic anti-inflammatory and osteogenic preclinical effects of this system. Methods: The targets and pathways of parthenolide and naringin were predicted. Three cell models were used to assess the anti-inflammatory effects of parthenolide and the osteogenic effects of naringin. First, the distance between the cementoenamel junction and alveolar bone crest (CEJ-ABC) and the bone mineral density (BMD) of surgical defects were measured in a rat model of periodontitis with periodontal fenestration defects. Additionally, the mRNA expression levels of matrix metallopeptidase 9 (MMP9) and alkaline phosphatase (ALP) were measured. Furthermore, the number of inflammatory cells and osteoclasts, as well as the protein expression levels of tumor necrosis factor-alpha (TNF-α) and levels of ALP were determined. Results: Target prediction suggested prostaglandin peroxidase synthase (PTGS2) as a potential target of parthenolide, while cytochrome P450 family 19 subfamily A1 (CYP19A1) and taste 2 receptor member 31 (TAS2R31) were potential targets of naringin. Parthenolide mainly targeted inflammation-related pathways, while naringin participated in steroid hormone synthesis and taste transduction. In vitro experiments revealed significant antiinflammatory effects of parthenolide on RAW264.7 cells, and significant osteogenic effects of naringin on bone marrow mesenchymal stem cells and MC3T3-E1 cells. DDDS loaded with parthenolide and naringin decreased the CEJ-ABC distance and increased BMD and ALP levels in a time-dependent manner. Inflammation was significantly alleviated after 14 days of DDDS treatment. Additionally, after 56 days, the DDDS group exhibited the highest BMD and ALP levels. Conclusions: DDDS loaded with parthenolide and naringin in a rat model achieved significant synergistic anti-inflammatory and osteogenic effects, providing powerful preclinical evidence.
참고문헌 (36)
- Straka M, "Periodontitis and osteoporosis", Neuroendocrinol Lett, 36, pp.401~406 (2015)
- Killoy WJ, "The clinical significance of local chemotherapies", J Clin Periodontol, 29(Suppl 2), pp.22~29 (2002)
- McAllister BS, "Bone augmentation techniques", J Periodontol, 78, pp.377~396 (2007)
- Cho YD, "An overview of biomaterials in periodontology and implant dentistry", Adv Mater Sci Eng, 2017, pp.1~7 (2017)
- Ma ZW, "A study on the effect of the chitosan thermosensitive hydrogel loading recombinant human bone morphogenetic protein-2 on repairing periodontal defects", Hua Xi Kou Qiang Yi Xue Za Zhi, 26, pp.23~26 (2008)
- Guo Z, "Sequential controlled-released dual-drug loaded scaffold for guided bone regeneration in a rat fenestration defect model", J Mater Chem B Mater Biol Med, 5, pp.7701~7710 (2017)
- Wang M, "Parthenolide could become a promising and stable drug with anti-inflammatory effects", Nat Prod Res, 29, pp.1092~1101 (2015)
- Li S, "Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells", Acta Biochim Biophys Sin(Shanghai), 47, pp.368~375 (2015)
- Li N, "Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis", J Orthop Sci, 18, pp.478~485 (2013)
- Pang WY, "Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like(UMR-106)cells", Br J Pharmacol, 159, pp.1693~1703 (2010)
- Keiser MJ, "Relating protein pharmacology by ligand chemistry", Nat Biotechnol, 25, pp.197~206 (2007)
- Liu X, "HitPick : a web server for hit identification and target prediction of chemical screenings", Bioinformatics, 29, pp.1910~1912 (2013)
- Daina A, "SwissTargetPrediction : updated data and new features for efficient prediction of protein targets of small molecules", Nucleic Acids Res, 47, pp.W357~W364 (2019)
- Warde-Farley D, "The GeneMANIA prediction server : biological network integration for gene prioritization and predicting gene function", Nucleic Acids Res, 38, pp.W214~W220 (2010)
- Snel B, "STRING : a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene", Nucleic Acids Res, 28, pp.3442~3444 (2000)
- Greene CS, "Understanding multicellular function and disease with human tissue-specific networks", Nat Genet, 47, pp.569~576 (2015)
- Seol YJ, "Preclinical methods for the evaluation of periodontal regeneration in vivo", Methods Mol Biol, 666, pp.285~307 (2010)
- Parsa A, "Bone quality evaluation at dental implant site using multislice CT, micro-CT, and cone beam CT", Clin Oral Implants Res, 26, pp.e1~e7 (2015)
- Yang X, "Puerarin decreases bone loss and collagen destruction in rats with ligature-induced periodontitis", J Periodontal Res, 50, pp.748~757 (2015)
- Zhou Y, "Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis", Free Radic Biol Med, 171, pp.55~68 (2021)
- da Silva-Junior IA, "Platelet-activating factor receptor ligands protect tumor cells from radiation-induced cell death", Front Oncol, 8, pp.10~ (2018)
- Shi FD, "Control of the autoimmune response by type 2 nitric oxide synthase", J Immunol, 167, pp.3000~3006 (2001)
- Di Nardo G, "Molecular and structural evolution of cytochrome P450 aromatase", Int J Mol Sci, 22, pp.631~ (2021)
- Zhang J, "P4HB, a novel hypoxia target gene related to gastric cancer invasion and metastasis", BioMed Res Int, 2019, pp.9749751~ (2019)
- Yin P, "Aged monkey brains reveal the role of ubiquitin-conjugating enzyme UBE2N in the synaptosomal accumulation of mutant huntingtin", Hum Mol Genet, 24, pp.1350~1362 (2015)
- Li Q, "MAPK usage in periodontal disease progression", J Signal Transduct, 2012, pp.308943~ (2012)
- Smallie T, "Dual-specificity phosphatase 1 and tristetraprolin cooperate to regulate macrophage responses to lipopolysaccharide", J Immunol, 195, pp.277~288 (2015)
- Kwok BH, "The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase", Chem Biol, 8, pp.759~766 (2001)
- Wang D, "Parthenolide ameliorates Concanavalin A-induced acute hepatitis in mice and modulates the macrophages to an anti-inflammatory state", Int Immunopharmacol, 38, pp.132~138 (2016)
- Feng D, "Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages", Inflamm Res, 59, pp.115~121 (2010)
- de Oliveira RR, "Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis : a preliminary randomized controlled clinical study", J Periodontol, 78, pp.965~973 (2007)
- Carda C, "Osteoprotegerin(OPG)and RANKL expression and distribution in developing human craniomandibular joint", Tissue Cell, 37, pp.247~255 (2005)
- Chen LL, "Osteogenic effect of Drynariae rhizoma extracts and Naringin on MC3T3-E1 cells and an induced rat alveolar bone resorption model", Arch Oral Biol, 56, pp.1655~1662 (2011)
- Yin L, "Effects of naringin on proliferation and osteogenic differentiation of human periodontal ligament stem cells in vitro and in vivo", Stem Cells Int, 2015, pp.758706~ (2015)
- Jo S, "Regulation of osteoblasts by alkaline phosphatase in ankylosing spondylitis", Int J Rheum Dis, 22, pp.252~261 (2019)
- Ji Y, "Controlled-release naringin nanoscaffold for osteoporotic bone healing", Dent Mater, 30, pp.1263~1273 (2014)